Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3167-3189

  Ragab, Doaa M ^a   Rohani, Sohrab ^a   Consta, Styliani ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

5 fluorouracil; Fickian diffusion; Nanoaggregates; Progesterone; Release kinetics

Indexed keywords

BETA CYCLODEXTRIN; FLUOROURACIL; MAGNETIC NANOPARTICLE; POLOXAMER; PROGESTERONE;

ARTICLE; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MAGNETIC FIELD; NANOENCAPSULATION; NANOPHARMACEUTICS; PARTICLE SIZE; POWDER; SLOW DRUG RELEASE; TIMED DRUG RELEASE; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CELL LINE, TUMOR; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FLUOROURACIL; HUMANS; KINETICS; MAGNETITE NANOPARTICLES; PARTICLE SIZE; POLOXAMER; PROGESTERONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84870360452     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S30190     Document Type: Article

References (32)

1. Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomedicine. 2009;4:299-319.
2. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56(6):588-599.
3. Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6(1):67-74.
4. Yang W, Johnston KP, Williams RO III. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm. 2010;75(1):33-41.
5. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release. 2002;79(1-3):29-40.
6. Makino K, Yamamoto N, Higuchi K, Harada N, Ohshima H, Terada H. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids and Surfaces B: Biointerfaces. 2003;27(1):33-39.
7. Hoet PH, Bruske-Hohlfeld I, Salata OV. Nanoparticles-known and unknown health risks. J Nanobiotechnology. 2004;2(1):12.
8. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785-796.
9. Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci U S A. 2002;99(19):12001-12005.
10. Hadinoto K, Phanapavudhikul P, Kewu Z, Tan RB. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. Int J Pharm. 2007;333(1-2):187-198.
11. Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008;364(1):64-75.
12. Kim BS, Qiu JM, Wang JP, Taton TA. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett. 2005;5(10):1987-1991.
13. Ge J, Hu Y, Biasini M, Beyermann WP, Yin Y. Superparamagnetic magnetite colloidal nanocrystal clusters. Angew Chem Int Ed Engl. 2007;46(23):4342-4345.
14. Tongwen X, Binglin H. Mechanism of sustained drug release in diffusion-controlled polymer matrix-application of percolation theory. Int J Pharm. 1998;170(2):139-149.
15. Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Controlled Release. 2011;154(1):2-19.
16. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics. 2000;50(1):27-46.
17. Edwards DA, Hanes J, Caponetti G, etal. Large porous particles for pulmonary drug delivery. Science. 1997;276(5320):1868-1871.
18. Dailey LA, Kleemann E, Wittmar M, etal. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA. Pharm Res. 2003;20(12):2011-2020.
19. Zhang C, Zhang H, Du B, Hou R, Guo S. Facile organic solvent-free synthesis of size-controlled hierarchically structured magnetic hollow spheres and potential application in adsorption for bovine serum album. J Colloid Interface Sci. 2012;368(1):97-106.
20. Kuznetsov AA, Filippov VI, Alyautdin RN, Torshina NL, Kuznetsov OA. Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs. J Magn Magn Mater. 2001;225(1-2):95-100.
21. Voigt A, Buske N, Sukhorukov GB, etal. Novel polyelectrolyte multilayer micro-and nanocapsules as magnetic carriers. J Magn Magn Mater. 2001;225(1-2):59-66.
22. Krahne R, Morello G, Figuerola A, George C, Deka S, Manna L. Physical properties of elongated inorganic nanoparticles. Physics Reports. 2011;501(3-5):75-221.
23. Jin J, Iyoda T, Cao C, etal. Self-Assembly of Uniform Spherical Aggregates of Magnetic Nanoparticles through pi-pi Interactions. Angew Chem Int Ed Engl. 2001;40(11):2135-2138.
24. Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm. 2008;364(2):328-343.
25. Xia H, Foo P, Yi J. Water-Dispersible Spherically Hollow Clusters of Magnetic Nanoparticles. Chem Mater. 2009;21(12):2442-2451. http://dx.doi.org/10.1021/cm900268z.
26. Lemos-Senna E, Wouessidjewe D, Lesieur S, Duchêne D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. Int J Pharm. 1998;170(1):119-128.
27. Shuguang Z. Emerging biological materials through molecular self-assembly. Biotechnol Adv. 2002;20(5-6):321-339.
28. Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Human Reproduction. 2007;22(5):1304-1309.
29. Rana S, Gallo A, Srivastava RS, Misra RDK. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: Functionalization, conjugation and drug release kinetics. Acta Biomaterialia. 2007;3(2):233-242.
30. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences. 2001;13(2):123-133.
31. Memişoǧlu E, Bochot A, şen M, Duchêne D, Hi{dotless}ncal AA. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. Int J Pharm. 2003;251(1-2):143-153.
32. Arias JL, Gallardo V, Ruiz MA, Delgado ÁV. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting. European Journal of Pharmaceutics and Biopharmaceutics. 2008;69(1):54-63.